Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice
Abstract An effective vaccine would be a valuable tool for malaria control and elimination; however, the leading malaria vaccine in development, RTS,S/AS01, provided only partial protection in a Phase 3 trial. R21 is a next-generation RTS,S-like vaccine. We have previously shown in mice that R21 adm...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/2049d091dd6f4297bcb5fc1522ae3a45 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|